Close Menu
World Economist – Global Markets, Finance & Economic Insights
  • Home
  • Economist Impact
    • Economist Intelligence
    • Finance & Economics
  • Business
  • Asia
  • China
  • Europe
  • Economy
  • USA
    • Middle East & Africa
    • Highlights
  • This week
  • World Economy
    • World News
What's Hot

Euro backs off four-year peak on profit-taking

July 7, 2025

Which currencies may trump the US dollar? Traders look to the yuan, the Aussie and the won

July 7, 2025

Chinese stocks may pay a record US$419 billion in 2025 dividends in bonanza for investors

July 7, 2025
Facebook X (Twitter) Instagram
Monday, July 7
Facebook X (Twitter) Instagram
World Economist – Global Markets, Finance & Economic Insights
  • Home
  • Economist Impact
    • Economist Intelligence
    • Finance & Economics
  • Business
  • Asia
  • China
  • Europe
  • Economy
  • USA
    • Middle East & Africa
    • Highlights
  • This week
  • World Economy
    • World News
World Economist – Global Markets, Finance & Economic Insights
Home » Ferozsons mulls buying Barrett Hodgson Pakistan with local consortium – Business & Finance
Economist Intelligence

Ferozsons mulls buying Barrett Hodgson Pakistan with local consortium – Business & Finance

adminBy adminMay 19, 2025No Comments2 Mins Read
Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
Share
Facebook Twitter Pinterest Email Copy Link
Post Views: 68


Ferozsons Laboratories Limited (FEROZ) is considering acquiring Barrett Hodgson Pakistan Pvt. Limited, a pharmaceutical company, in partnership with a consortium of prominent Pakistani business groups.

The listed company shared the development in a notice to the Pakistan Stock Exchange (PSX) on Monday.

“The Board of Directors (BoD) in their emergent board meeting held on May 17, 2025 reviewed the proposal recommended by the investment committee for the potential acquisition of Barrett Hodgson Pakistan Pvt. Limited, in conjunction with a consortium comprising leading business groups of Pakistan,” read the notice.

As per the notice, the BoD further authorised the Chief Executive Officer and the Chief Financial Officer to perform due diligence, appoint advisors, sign all the documents in this respect and to do all other acts, including giving bid money, security, etc., in connection with the aforesaid potential acquisition.

“The final purchase price and equity investment will be approved by BoD based on the outcome of due diligence and other parameters, including relevant approvals,” FEROZ added.

Manufacturing HIV drug in Pakistan: Ferozsons partners with US-based Gilead

As per information available on the Barrett Hodgson Pakistan (BHP) website, the company ranks among the top 15 pharmaceutical companies in Pakistan. “While catering to almost all the medicinal categories and specialities with quality products at affordable prices, we exist in the healthcare sector with a comprehensive portfolio of over 100 brands and 240 formulations,” the company states.

Meanwhile, Ferozsons Laboratories Limited, incorporated in Pakistan as a public limited company in 1954 and later converted into a public limited company in 1960, is engaged in the manufacturing, import and sale of pharmaceutical products and medical devices.

At the time of filing this report, FEROZ’s share price stood at Rs294.50, registering an increase of Rs15.22 or 5.45%.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
admin
  • Website

Related Posts

Economist Intelligence

India’s stock benchmarks to open flat on caution ahead of US tariff deadline – Markets

July 7, 2025
Economist Intelligence

Indian rupee to track Asian peers lower after Trump flags return to higher tariffs if no deal – Markets

July 7, 2025
Economist Intelligence

Gold falls on trade deal progress, tariff reprieve extension – Markets

July 7, 2025
Economist Intelligence

Trump says US nears trade deals as tariff effective date delayed – Markets

July 7, 2025
Economist Intelligence

Dollar pinned near multi-year lows as Trump tariff deadline looms – Markets

July 7, 2025
Economist Intelligence

Egypt’s non-oil business conditions deteriorate further in June, PMI shows – Business & Finance

July 6, 2025
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

India’s stock benchmarks to open flat on caution ahead of US tariff deadline – Markets

July 7, 2025

Indian rupee to track Asian peers lower after Trump flags return to higher tariffs if no deal – Markets

July 7, 2025

Gold falls on trade deal progress, tariff reprieve extension – Markets

July 7, 2025

Trump says US nears trade deals as tariff effective date delayed – Markets

July 7, 2025
Latest Posts

PSX hits all-time high as proposed ‘neutral-to-positive’ budget well-received by investors – Business

June 11, 2025

Sindh govt to allocate funds for EV taxis, scooters in provincial budget: minister – Pakistan

June 11, 2025

US, China reach deal to ease export curbs, keep tariff truce alive – World

June 11, 2025

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Recent Posts

  • Euro backs off four-year peak on profit-taking
  • Which currencies may trump the US dollar? Traders look to the yuan, the Aussie and the won
  • Chinese stocks may pay a record US$419 billion in 2025 dividends in bonanza for investors
  • Yen moves in a negative zone as the week opens up
  • China’s Li Qiang urges Brics bloc action as Trump tariff deadline looms

Recent Comments

No comments to show.

Welcome to World-Economist.com, your trusted source for in-depth analysis, expert insights, and the latest news on global finance and economics. Our mission is to provide readers with accurate, data-driven reports that shape the understanding of economic trends worldwide.

Latest Posts

Euro backs off four-year peak on profit-taking

July 7, 2025

Which currencies may trump the US dollar? Traders look to the yuan, the Aussie and the won

July 7, 2025

Chinese stocks may pay a record US$419 billion in 2025 dividends in bonanza for investors

July 7, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • June 2024
  • October 2022
  • March 2022
  • July 2021
  • February 2021
  • January 2021
  • November 2019
  • April 2011
  • January 2011
  • December 2007
  • July 2007

Categories

  • AI & Tech
  • Asia
  • Banking
  • Business
  • Business
  • China
  • Climate
  • Computing
  • Economist Impact
  • Economist Intelligence
  • Economy
  • Editor's Choice
  • Europe
  • Europe
  • Featured
  • Featured Business
  • Featured Climate
  • Featured Health
  • Featured Science & Tech
  • Featured Travel
  • Finance & Economics
  • Health
  • Highlights
  • Markets
  • Middle East
  • Middle East & Africa
  • Middle East News
  • Most Viewed News
  • News Highlights
  • Other News
  • Politics
  • Russia
  • Science
  • Science & Tech
  • Social
  • Space Science
  • Sports
  • Sports Roundup
  • Tech
  • This week
  • Top Featured
  • Travel
  • Trending Posts
  • Ukraine Conflict
  • Uncategorized
  • US Politics
  • USA
  • World
  • World & Politics
  • World Economy
  • World News
© 2025 world-economist. Designed by world-economist.
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.